Characterizing Biomarkers of Early Parkinson's Disease Progression (TREG)
NCT03716258 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 16
Last updated 2022-04-20
Summary
The purpose of this study is to look at a blood marker of inflammation in early untreated Parkinson's disease.
Conditions
- Parkinson Disease
- Movement Disorders
Sponsors & Collaborators
-
Portland VA Medical Center
collaborator FED -
Oregon Health and Science University
lead OTHER
Principal Investigators
-
Joseph F Quinn, MD · Oregon Health and Science University
Eligibility
- Min Age
- 40 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-01-01
- Primary Completion
- 2021-05-01
- Completion
- 2021-05-01
Countries
- United States
Study Locations
More Related Trials
-
EMG Modules as a Novel Biomarker of Basal Ganglia Plasticity in Parkinson's Disease
NCT02896816 ·Status: TERMINATED ·Phase: NA
-
Identification of a Biomarker Predictive of Evolution of Parkinson Disease
NCT03230526 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Early Longitudinal Imaging in Parkinson's Progression Markers Initiative Using [¹⁸F] AV-133 and DaTscan™
NCT04507139 ·Status: ACTIVE_NOT_RECRUITING
-
Study for the Early Diagnosis of Parkinson's Disease
NCT02283073 ·Status: UNKNOWN
-
Development of Imaging, Clinical and Biochemical Bio-Markers for Parkinson's Disease
NCT00315250 ·Status: COMPLETED ·Phase: PHASE2
-
Parkinson's Disease Exercise TMS PET Study
NCT02265900 ·Status: TERMINATED ·Phase: NA
-
Cell Studies of Parkinson's Disease
NCT00076505 ·Status: COMPLETED
-
Parkinson's Repository of Biosamples and Network Datasets (Tracking Parkinson's)
NCT02881099 ·Status: COMPLETED
-
Biomarker Analysis for GBA Associated Parkinson's Disease
NCT03811496 ·Status: UNKNOWN
-
Imaging and Genetic Biomarkers of Parkinson Disease (PD) Onset and Progression in High-risk Families
NCT00273351 ·Status: COMPLETED ·Phase: PHASE2
-
Objective, Passive Assessment of LRRK2 Carriers
NCT05287620 ·Status: COMPLETED
-
Development of an Instrumented System to Measure Mobility in Parkinson's Disease
NCT01174758 ·Status: COMPLETED
-
Blood Biomarker in Early Parkinson's Disease
NCT03384797 ·Status: COMPLETED
-
Genetic Influences on Response to Gait Rehabilitation in Parkinson's Disease
NCT03607695 ·Status: COMPLETED ·Phase: NA
-
Early Biomarkers in Premanifest Huntington's Disease Gene Carriers: a Pilot Study
NCT06626308 ·Status: RECRUITING ·Phase: NA
-
Measuring Parkinson's Disease Progression
NCT03205956 ·Status: COMPLETED ·Phase: PHASE1
-
Identification of Motor Symptoms Related to Parkinson's Disease Using Motion Tracking Sensors at Home
NCT03366558 ·Status: COMPLETED
-
Parkinson's Disease Inflammatory Biomarker Profiling
NCT03633513 ·Status: TERMINATED
-
Predictors of Motor Progression in Parkinson's Disease
NCT02769039 ·Status: COMPLETED
-
Exercise, Brain Imaging, Cognition, and Gait in Parkinsonism
NCT02231073 ·Status: COMPLETED ·Phase: NA
-
Diagnostic and Prognostic Biomarkers in Parkinson Disease
NCT00653783 ·Status: UNKNOWN
-
A Non-interventional Study for the Collection of Biospecimens From Patients With Parkinson's Disease
NCT04893083 ·Status: TERMINATED
-
LRRK2 Activity and Markers of Parkinson's Disease in G2385R Carriers
NCT04349865 ·Status: COMPLETED
-
Research of Biomarkers in Parkinson Disease
NCT00465790 ·Status: COMPLETED
-
Wearable Assessments in the Clinic and Home in PD
NCT03681015 ·Status: COMPLETED